海外の治験の状況「濾胞性リンパ腫」での検索結果
1540件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma
- Lymphoma, Follicular
- Greece
- 2012-05-29
Not Recruiting
- Clinical study to investigate the efficacy of rituximab monotherapy after the rituximab combination chemotherapy for previously untreated follicular lymphoma<THF019>
- follicular lymphoma
- Japan
- 2012-05-23
Not Recruiting
- A study of GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (a type of cancer)
- Advanced Stage Follicular Lymphoma
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, France, Germany, Greece, Hungary, India, Ireland, Israel, Italy, Japan, Malaysia, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Ukraine
- 2012-04-19
Not recruiting
- Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma
- Follicular Non-Hodgkin's Lymphoma
- Italy
- 2013-11-21
Not recruiting
- Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma
- Follicular Lymphoma
- Norway
- 2013-08-19
Authorised
- A multicenter, open-label study of INCB050465 in patients with relapsed or refractory follicular lymphoma
- Follicular Lymphoma br>MedDRA version: 20.0 Level: LLT Classification code 10067070 Term: Follicular B-cell non-Hodgkin's lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Czech Republic, Denmark, Germany, Hungary, Israel, Italy, Poland, Spain, Sweden, United Kingdom, United States
- 2017-10-17
Authorised
- A multicenter, open-label study of INCB050465 in patients with relapsed or refractory follicular lymphoma
- Follicular Lymphoma br>MedDRA version: 20.0 Level: LLT Classification code 10067070 Term: Follicular B-cell non-Hodgkin's lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Czech Republic, Denmark, Germany, Hungary, Israel, Italy, Poland, Spain, Sweden, United Kingdom, United States
- 2017-10-16
Recruiting
- An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
- Lymphoma
- Australia, Canada, Czechia, Denmark, Germany, Hungary, Israel, Italy, Poland, Spain, Sweden, United Kingdom, United States
- 2017-04-20
Recruiting
- Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
- Treatment Naive Follicular Lymphoma
- Australia, Austria, Belgium, Canada, Czechia, France, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2016-10-26
Recruiting
- Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
- Follicular Lymphoma
- United States
- 2018-06-23